Korean Paper    Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Diabetes Mellitus the Declare-Diabetes Trial (a Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol (2008) 51;1181-7 S. W. Lee, et al. Explaining Age-Specific Inequalities in Mortality from All Causes, Cardiovascular Disease and Ischaemic Heart Disease among South Korean Male Public Servants: Relative and Absolute Perspectives Heart (2008) 94;75-82 Y. H. Khang, et al. Physiological Evaluation of the Provisional Side-Branch Intervention Strategy for Bifurcation Lesions Using Fractional Flow Reserve Eur Heart J (2008) 29;726-732 B. K. Koo, et al. Long-Term Clinical Outcomes after Sirolimus-Eluting Stent Implantation for Treatment of Restenosis within Bare-Metal Versus Drug-Eluting Stents Catheter Cardiovasc Interv (2008) 71;594-8 C. Whan Lee, et al. Late Target Lesion Revascularization after Implantation of Sirolimus-Eluting Stent Catheter Cardiovasc Interv (2008) 71;299-303 M. K. Hong, et al. A Three-Vessel Virtual Histology Intravascular Ultrasound Analysis of Frequency and Distribution of Thin-Cap Fibroatheromas in Patients with Acute Coronary Syndrome or Stable Angina Pectoris Am J Cardiol (2008) 101;568-72 M. K. Hong, et al. Frequency of Coronary Arterial Late Angiographic Stent Thrombosis (Last) in the First Six Months: Outcomes with Drug-Eluting Stents Versus Bare Metal Stents Am J Cardiol (2007) 99;774-8 D. W. Park, et al. Results and Predictors of Angiographic Restenosis and Long-Term Adverse Cardiac Events after Drug-Eluting Stent Implantation for Aorto-Ostial Coronary Artery Disease Am J Cardiol (2007) 99;760-5 D. W. Park, et al. Comparison of Six-Month Angiographic and Three-Year Outcomes after Sirolimus-Eluting Stent Implantation Versus Brachytherapy for Bare Metal in-Stent Restenosis Am J Cardiol (2007) 100;425-30 S. W. Lee, et al. Comparison of Triple Versus Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation (from the Declare-Long Trial) Am J Cardiol (2007) 100;1103-8 S. W. Lee, et al. Frequency of Stent Fracture as a Cause of Coronary Restenosis after Sirolimus-Eluting Stent Implantation Am J Cardiol (2007) 100;627-30 S. H. Lee, et al. Sirolimus-Eluting Stent Implantation for Treatment of Proximal Left Anterior Descending Coronary Artery Lesions: Long-Term Outcome and Predictors of Adverse Cardiac Events Catheter Cardiovasc Interv (2007) 70;368-73 C. W. Lee, et al. Incidence and Predictors of Recurrent Restenosis Following Implantation of Drug-Eluting Stents for in-Stent Restenosis Catheter Cardiovasc Interv (2007) 69;104-8 C. W. Lee, et al. Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) on Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent Implantation Am J Cardiol (2007) 100;610-4 B. K. Lee, et al. Effect of Celecoxib on Restenosis after Coronary Angioplasty with a Taxus Stent (Corea-Taxus Trial): An Open-Label Randomised Controlled Study Lancet (2007) 370;567-74 B. K. Koo, et al. Intracoronary Infusion of the Mobilized Peripheral Blood Stem Cell by G-Csf Is Better Than Mobilization Alone by G-Csf for Improvement of Cardiac Function and Remodeling: 2-Year Follow-up Results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-Csf and Intra-Coronary Stem Cell Infusion (Magic Cell) 1 Trial Am Heart J (2007) 153;237 e1-8 H. J. Kang, et al. Comparison of Virtual Histology to Intravascular Ultrasound of Culprit Coronary Lesions in Acute Coronary Syndrome and Target Coronary Lesions in Stable Angina Pectoris Am J Cardiol (2007) 100;953-9 M. K. Hong, et al. Effects of Balloon-Based Distal Protection During Primary Percutaneous Coronary Intervention on Early and Late Infarct Size and Left Ventricular Remodeling: A Pilot Study Using Serial Contrast-Enhanced Magnetic Resonance Imaging Am Heart J (2007) 153;665 e1-8 J. Y. Hahn, et al.